Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 8.61 | 1,982 | 17.07 k | 18,385 |
30 Sep 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 12.77 | 1,311 | 16.74 k | 16,403 |
30 Jun 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 13.93 | 1,202 | 16.74 k | 15,092 |
25 Jun 24 | RENB Renovaro Biosciences | Option to purchase shares of common stock Common stock | Grant | Acquire A | No | No | 1.61 | 48,137 | 77.50 k | 48,137 |
12 Jun 24 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,670 | 0.00 | 10,470 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,420 | 0.00 | 10,420 |
12 Jun 24 | NVAX Novavax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.86 | 15,630 | 247.89 k | 15,630 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,670 | 0.00 | 0 |
17 May 24 | CORT Corcept Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 28.09 | 30,000 | 842.70 k | 30,000 |
31 Mar 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 4.9 | 3,420 | 16.76 k | 7,220 |